This activity reviews the incidence and impact of opioid-induced constipation (OIC), discusses available treatment options, and what factors should be considered during formulary decisions for OIC.
Steven R. Peskin, MD, MBA, FACP
Advertisement
Articles by Steven R. Peskin, MD, MBA, FACP
Advertisement
Latest Updated Articles
- Opioid-Induced Constipation: Considerations for Formulary Decision Makers
Published: June 19th 2015 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Recognizing Immunizing Pharmacists in the Community
2
Denosumab Biosimilars Conexxence and Bomyntra Receive Interchangeability Designation
3
PCV20 Demonstrates Real-World Effectiveness Against Pneumonia in Older Adults
4
Evidence Suggests Long-Term Cognitive Impact of Benzodiazepines
5
